lgd2941

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

  • AR modulator

    Selective androgen modulator (SARM). No information about further clinical development (http://www.drugs.com/clinical_trials/ligand-research-published-journal-medicinal-chemistry-lgd-2941-shows-promise-treating-muscle-bone-2222.html)

Chemistry & pharmacology

Loading structure…

SMILES

C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1
Mol. weight
394.31 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 6-(2-methyl-5-(2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-4-trifluoromethylquinolin-2(1h)-one
  • lgd2941
  • lgd2941
  • lgd 2941
  • lgd-2941
  • lgd-2941
  • lgd-2941